{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:37:00Z","timestamp":1648550220308},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00063-010-1049-z","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T04:58:28Z","timestamp":1273294708000},"page":"237-241","source":"Crossref","is-referenced-by-count":0,"title":["Neuroendokrines Karzinom der Lunge: eine diagnostische und therapeutische Herausforderung"],"prefix":"10.1007","volume":"105","author":[{"given":"Claudia","family":"B\u00f6ttger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Warth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Nawroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berend","family":"Isermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,9]]},"reference":[{"key":"1049_CR1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.119.6.1647","volume":"119","author":"G. Fink","year":"2001","unstructured":"Fink G, Krelbaum T, Yellin A, et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Isreal and review of 640 cases from the literature. Chest 2001;119:1647\u201351.","journal-title":"Chest"},{"key":"1049_CR2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"I.M. Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934\u201359.","journal-title":"Cancer"},{"key":"1049_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-5002(02)00080-6","volume":"37","author":"H. Skuladottir","year":"2002","unstructured":"Skuladottir H, Hirsch FR, Hansen HH, Olsen JH. Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer 2002;37:127\u201335.","journal-title":"Lung Cancer"},{"key":"1049_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cncr.23542","volume":"113","author":"B.I. Gustafsson","year":"2008","unstructured":"Gustafsson BI, Kidd M, Chan A, et al. Bronchopulmonary neuroendocrine tumors. Cancer 2008;113:5\u201321.","journal-title":"Cancer"},{"key":"1049_CR5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00000478-199808000-00003","volume":"22","author":"W.D. Travis","year":"1998","unstructured":"Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998;22:934\u201344.","journal-title":"Am J Surg Pathol"},{"key":"1049_CR6","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/MEG.0b013e3282294d88","volume":"19","author":"D. Papadogias","year":"2007","unstructured":"Papadogias D, Makras P, Kossivakis K, et al. Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challenge. Eur J Gastroenterol Hepatol 2007;19:1154\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1049_CR7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.athoracsur.2009.02.042","volume":"88","author":"J.D. Phillips","year":"2009","unstructured":"Phillips JD, Yeldandi A, Blum M, de Hoyos A. Bronchial carcinoid secreting insulin-like growth factor-1 with acromegalic features. Ann Thorac Surg 2009;88:1350\u20132.","journal-title":"Ann Thorac Surg"},{"key":"1049_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/RLU.0b013e3181a7d22e","volume":"34","author":"S.M. Corsello","year":"2009","unstructured":"Corsello SM, Fintini D, Lovicu RM, et al. Ectopic ACTH syndrome due to occult bronchial carcinoid. Clin Nucl Med 2009;34:459\u201361.","journal-title":"Clin Nucl Med"},{"key":"1049_CR9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1010-7940(02)00089-1","volume":"21","author":"I.C. Kurul","year":"2002","unstructured":"Kurul IC, Topcu S, Tastepe I, et al. Surgery in bronchial carcinoids: experience with 83 patients. Eur J Cardiothorac Surg 2002;21:883\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1049_CR10","first-page":"712","volume":"7","author":"A. Yellin","year":"2005","unstructured":"Yellin A, Zwas ST, Rozenman J, et al. Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors. Isr Med Assoc J 2005;7:712\u20136.","journal-title":"Isr Med Assoc J"},{"key":"1049_CR11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MNM.0b013e32832999c1","volume":"30","author":"V. Ambrosini","year":"2009","unstructured":"Ambrosini V, Castellucci P, Rubello D, et al. 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid. Nucl Med Commun 2009;30:281\u20136.","journal-title":"Nucl Med Commun"},{"key":"1049_CR12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1158\/1078-0432.CCR-07-1631","volume":"14","author":"M. Rugge","year":"2008","unstructured":"Rugge M, Fassan M, Clemente R, et al. Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. Clin Cancer Res 2008;14:149\u201354.","journal-title":"Clin Cancer Res"},{"key":"1049_CR13","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.athoracsur.2003.10.089","volume":"77","author":"G. Cardillo","year":"2004","unstructured":"Cardillo G, Sera F, Di Martino M, et al. Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg 2004;77:1781\u20135.","journal-title":"Ann Thorac Surg"},{"key":"1049_CR14","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1097\/JTO.0b013e31818e0dd4","volume":"3","author":"B.G. Skov","year":"2008","unstructured":"Skov BG, Krasnik M, Lantuejoul S, et al. Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival. J Thorac Oncol 2008;3:1410\u20135.","journal-title":"J Thorac Oncol"},{"key":"1049_CR15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1378\/chest.119.4.1143","volume":"119","author":"C.F. Thomas Jr","year":"2001","unstructured":"Thomas CF Jr, Tazelaar HD, Jett JR. Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 2001;119:1143\u201350.","journal-title":"Chest"},{"key":"1049_CR16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1378\/chest.130.5.1405","volume":"130","author":"L. Bertoletti","year":"2006","unstructured":"Bertoletti L, Elleuch R, Kaczmarek D, et al. Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor. Chest 2006;130:1405\u201311.","journal-title":"Chest"},{"key":"1049_CR17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtcvs.2006.12.013","volume":"133","author":"H.A. Brokx","year":"2007","unstructured":"Brokx HA, Risse EK, Paul MA, et al. Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids. J Thorac Cardiovasc Surg 2007;133:973\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1049_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(94)70444-9","volume":"107","author":"N. Martini","year":"1994","unstructured":"Martini N, Zaman MB, Bains MS, et al. Treatment and prognosis in bronchial carcinoids involving regional lymph nodes. J Thorac Cardiovasc Surg 1994;107:1\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1049_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000421-199706000-00016","volume":"20","author":"P. Perkins","year":"1997","unstructured":"Perkins P, Kemp BL, Putnam JB Jr, Cox JD. Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior. Am J Clin Oncol 1997;20:285\u20138.","journal-title":"Am J Clin Oncol"},{"key":"1049_CR20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2005-837539","volume":"53","author":"D. Divisi","year":"2005","unstructured":"Divisi D, Crisci R. Carcinoid tumors of the lung and multimodal therapy. Thorac Cardiovasc Surg 2005;53:168\u201372.","journal-title":"Thorac Cardiovasc Surg"},{"key":"1049_CR21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1210\/jc.2008-1712","volume":"94","author":"M. Hoek van","year":"2009","unstructured":"van Hoek M, Hofland LJ, de Rijke YB, et al. Effects of somatosatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies. J Clin Endocrinol Metab 2009;94:428\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"1049_CR22","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"A. Rinke","year":"2009","unstructured":"Rinke A, Muller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009;27:4656\u201363.","journal-title":"J Clin Oncol"},{"key":"1049_CR23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","volume":"28","author":"J.C. Yao","year":"2010","unstructured":"Yao JC, Lombard-Bohas C, Baudin E, et al. Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. J Clin Oncol 2010;28:69\u201376.","journal-title":"J Clin Oncol"},{"key":"1049_CR24","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1200\/JCO.2007.15.9020","volume":"26","author":"M.H. Kulke","year":"2008","unstructured":"Kulke MH, Lenz HJ, Meropol NJ, et al. Activity of sunitinib in patients with advanced neuroendocrine tumors. J Clin Oncol 2008;26:3403\u201310.","journal-title":"J Clin Oncol"}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-010-1049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-010-1049-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-010-1049-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T12:24:44Z","timestamp":1591273484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-010-1049-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1049"],"URL":"https:\/\/doi.org\/10.1007\/s00063-010-1049-z","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"value":"0723-5003","type":"print"},{"value":"1615-6722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}